 Our primary objective is to facilitate the deprescription of benzodiazepine and non-benzodiazepine sedative hypnotics sedatives using a combination of physician education sessions and an updated patient educational pamphlet based on Tannenbaums EMPOWER study conducted in a community-based setting. 